Patents by Inventor Daniel Lundell

Daniel Lundell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mammalian TNF-.alpha. convertases
    Patent number: 5853977
    Abstract: The present invention provides isolated human and bovine TNF-.alpha. convertases, nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods for making the convertases using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the convertases and are useful for treating medical conditions caused or mediated by TNF-.alpha.. Also provided are screening methods for identifying specific inhibitors of mammalian TNF-.alpha. convertases, and for identifying nucleic acids encoding such convertases.
    Type: Grant
    Filed: July 10, 1997
    Date of Patent: December 29, 1998
    Assignee: Schering Corporation
    Inventors: Barbara Dalie, Xuedong Fan, Daniel Lundell, Charles A. Lunn, Jimmy C. Tan, Paul J. Zavodny
  • Expression of human inducible nitric oxide synthase
    Patent number: 5744340
    Abstract: Biologically active human inducible nitric oxide synthase (iNOS) is expressed in E. coli. The expression of soluble, active iNOS is dependent on its coexpression with calmodulin.
    Type: Grant
    Filed: June 9, 1995
    Date of Patent: April 28, 1998
    Assignee: Schering Corporation
    Inventors: James D. Fossetta, Charles A. Lunn, Daniel Lundell